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Background: In clinical practice, research, and increasingly health surveillance, planning and costing, there is a
need for high quality information to determine comorbidity information about patients. Electronic, routinely
collected healthcare data is capturing increasing amounts of clinical information as part of routine care. The aim of
this study was to assess the validity of routine hospital administrative data to determine comorbidity, as compared
with clinician-based case note review, in a large cohort of patients with chronic kidney disease.
Methods: A validation study using record linkage. Routine hospital administrative data were compared with
clinician-based case note review comorbidity data in a cohort of 3219 patients with chronic kidney disease. To
assess agreement, we calculated prevalence, kappa statistic, sensitivity, specificity, positive predictive value and
negative predictive value. Subgroup analyses were also performed.
Results: Median age at index date was 76.3 years, 44% were male, 67% had stage 3 chronic kidney disease and
31% had at least three comorbidities. For most comorbidities, we found a higher prevalence recorded from case
notes compared with administrative data. The best agreement was found for cerebrovascular disease (κ = 0.80)
ischaemic heart disease (κ = 0.63) and diabetes (κ = 0.65). Hypertension, peripheral vascular disease and dementia
showed only fair agreement (κ = 0.28, 0.39, 0.38 respectively) and smoking status was found to be poorly recorded
in administrative data. The patterns of prevalence across subgroups were as expected and for most comorbidities,
agreement between case note and administrative data was similar. Agreement was less, however, in older ages
and for those with three or more comorbidities for some conditions.
Conclusions: This study demonstrates that hospital administrative comorbidity data compared moderately well
with case note review data for cerebrovascular disease, ischaemic heart disease and diabetes, however there was
significant under-recording of some other comorbid conditions, and particularly common risk factors.
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The importance of electronic, routinely collected health
care information has been at the forefront of discussion in
recent years. Substantial investment by healthcare pro-
viders internationally in digital health systems is capturing* Correspondence: corri.black@abdn.ac.uk
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tine care [1-3]. The potential application of such data ex-
tends beyond the ‘day to day care’ of individual patients;
with important roles in planning and costing health ser-
vices, population health surveillance and research.
In the UK, information about an episode of hospital
care is recorded following a patient’s discharge. Details
of diagnoses are coded using the World Health Organi-
sation’s International Classification of Disease (ICD) [4].
In Scotland, this information is recorded on the Scottish. This is an Open Access article distributed under the terms of the Creative
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by the Information Services Division (ISD), part of NHS
National Services Scotland, and data have been rou-
tinely available since 1980. The accuracy of such data
is important to a wide range of users. Changes in cod-
ing practice, administration systems and the increasing
complexity of patients’ health care records, driven by
increasing life expectancy, and the growing burden of
chronic disease, may all impact on the quality of re-
corded data. Quality assurance assessment of the re-
cording of clinical codes for diagnoses associated with
individual episodes of hospitalisation for Scottish hos-
pital episode data in 2010–11, has shown high accuracy
(88% for the Main Condition and 82% for Other Con-
ditions) [5].
Comorbidity describes the burden of illness co-
existing with a particular disease of interest which may
impact on patient outcomes. Comorbidity is an import-
ant dimension in health care that is under-reported and
under-investigated due to methodological challenges in
its assessment. In clinical practice, research, and in-
creasingly health surveillance, planning and costing,
there is a need for high quality information to deter-
mine comorbidity information about patients. Here, ra-
ther than a single hospital episode being reviewed,
longer periods of data might be examined for evidence of
comorbid conditions. Traditionally, clinician-based case
note review (CNR) has been regarded as the ‘gold’ stand-
ard method of extracting comorbidity information. How-
ever, CNR is labour- and resource-intensive. Electronic,
routinely collected healthcare data offer a potentially im-
portant alternative approach [6,7].
A systematic review published in 2009 [8] reported
that routine administrative data had limited validity for
comorbidity assessment. However, the studies were
often small, included only selected diagnoses, and none
were from the UK. Recent studies assessing routinely
collected comorbidity data in cohorts of patients with
disease demonstrate the variability in results, reporting
kappa coefficients of 0.67 to 0.93 [9] and 0.32 to 0.75
[10]. In addition, recent updates have shown a slight
improvement in coding of comorbidity over time when
looking at the validity of single episode coding of co-
morbidity [11].
Patients with chronic kidney disease (CKD) are often
elderly and the presence of comorbidity is common;
the cohort used in this study provides a useful model
for understanding the recording of comorbidity in rou-
tine administrative data as compared to clinician-based
CNR, particularly in those with a chronic disease. Here we
aim to present a validation study of hospital episode data
(with five years look-back) compared with clinician-based
CNR as a means of identifying comorbidity in a CKD co-
hort in the UK.Methods
Study design
We undertook a validation study using record linkage. An
established population based clinical cohort for CKD, the
Grampian Laboratory Outcomes Mortality and Morbidity
Study-1 (GLOMMS-I) was linked to a routinely collected
hospital administrative dataset.
GLOMMS-I
The GLOMMS-I cohort, which comprised 3426 patients
with moderate to severe CKD identified from the general
population, is described elsewhere [12]. GLOMMS-I par-
ticipants were identified from screening of all routine la-
boratory biochemistry data collected from hospital and
primary care for a population of 433,109 adults (>15 years
of age) representing a single health administrative region
in the North East of Scotland between 1 January and 30
June 2003. Individuals were included in GLOMMS-I if
they met the Kidney Disease Outcomes Quality Initiative
(KDOQI) definition of stage 3 to 5 CKD [13] (glomerular
filtration rate (GFR) < 60 mL/min/1.73 m2 for at least
three months). The date of the first estimated GFR
(eGFR) <60 mL/min/1.73 m2 during the period January to
June 2003 was taken as the ‘index’ date for each patient.
Case note review and administrative data
For this validation study, data were derived from the
GLOMMS-I cohort and linked with a hospital administra-
tive dataset that recorded discharge diagnoses for all hos-
pitalisations in the region (SMR01). In GLOMMS-I, CNR
had been undertaken to establish baseline comorbidity.
Clinical information had been extracted from patients’
hospital medical records by two physicians, experienced in
nephrology and general medicine, and blinded to the
SMR01 data. Information was recorded on a standardised
form. Data were entered by a data co-ordinator and a 10%
sample checked for accuracy by an independent assessor.
Data were collected on selected comorbidities (cerebro-
vascular disease, peripheral vascular disease, congestive
cardiac failure, types I and II diabetes mellitus, dementia,
chronic obstructive pulmonary disease, connective tissue
diseases, haematological malignancy, non-haematological
malignancy, chronic liver disease and smoking status)
present at any time prior to, but not including any admis-
sions at the time of the index blood sample. Data were
also collected on ischaemic heart disease and hyperten-
sion, however these events were recorded up to one year
post-index.
In Scotland, information about an episode of hospital care
is recorded on the SMR01, and diagnoses are classified ac-
cording to ICD-10 [4]. All relevant diagnoses and proce-
dures identified and recorded by medical personnel during
admission are, following discharge, then coded by trained
professional coders using appropriate documentation, which
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cords. Comorbidities thought to be important to out-
come in CKD and that contribute to Charlson were
included. Codes were identified for these comorbidities
from the ICD-10 manual (Table 1). SMR01 data were
obtained for all diagnoses, except for ischaemic heart
disease and hypertension, for the five years prior to the
index date, excluding admission at index date. For is-
chaemic heart disease and hypertension, SMR01 data
for the year 2003 were included to match CNR time
periods.
SMR01 and CNR definitions of included comorbidities
are available in Additional file 1. A measure of rurality
(Scottish Government 6-fold Urban Rural Classification
[14]) and socioeconomic status (Scottish Index of Multiple
Deprivation (SIMD) 2009 quintiles) [15] were also ob-
tained through linkage of patient postcode at baseline with
administrative data.
Data linkage
SMR01 data for the selected comorbidities were provided
by ISD [16]. The Community Health Index (CHI) number,
a unique patient identifier used throughout the Scottish
health care system, was used to link GLOMMS-I patients
with their SMR01 data using deterministic matching. Pa-
tient identifiers were removed after data linkage. The data-
set was stored in the Grampian Data Safe Haven allowing
secure controlled access for researchers while ensuring
data security [17]. Because of inconsistencies in the CHITable 1 ICD-10 codes for diagnoses
Diagnosis ICD-10 Code (2007 version)
Ischaemic heart disease I20 to I25
Hypertension I10 to I15, I67.4, I70.1, O10, O11
Cerebrovascular disease I60.x-I69.x, G45.x, G46.x, H34.0, I63,
I64, I69.3, I69.4
Peripheral vascular disease I70.x, I71.x, I73.1, I73.8, I73.9, I77.1, I79.0, I79.2
Congestive cardiac failure I50.x, I11.0, I13.0, I13.2, I25.5,
I42.0, I42.5–I42.9, I43.x
Diabetes mellitus E10, O24.0, E11, O24.1, E14, E13, E12
Dementia F01, F00, F03, F02, F05.1, G30, G31.1
Chronic obstructive
pulmonary disease
I27.8, I27.9, J40-J47, J60-J67,
J68.4, J70.1, J70.3
Connective tissue disease M05, M06, M07, M08, M30, M31,
M32, M33, M34, M35, M45
Haematological
malignancy
C81 to C96
Non-haematological
malignancy
C00 to C75, C76 to C80, C97
Chronic liver disease B18, K70.0, K70.2-70.9, K70.0-70.3, K71.3-71.5,
K71.7, K71.1, K72.9, K76.5, K72.1, K73, K74,
K76.6, K76.7, K76.0, K76.2-76.4, K76.8,
K76.9, Z94.4, I85.0, I85.9, I86.4, I98.2
Smoking status Z72.0, F17.2, Z71.6number and other data, 206 individuals from GLOMMS-I
did not have both CNR and SMR01 data, and were ex-
cluded. There was one duplicate record which was also ex-
cluded. Overall, 3219 patients were included in this study.
Statistical analysis
Descriptive analyses were performed reporting counts
and percentages. To assess agreement between CNR and
SMR01 recorded comorbidity (with CNR serving as the
reference), prevalence, kappa statistic, sensitivity, specifi-
city, positive predictive value and negative predictive
value were calculated for each comorbidity, and 95%
confidence intervals (CI) calculated using the Wilson
method [18]. The kappa statistic is a measure of agree-
ment between two sets of categorical measurements on
the same individuals, first categorised by Landis and
Koch [19]. We categorised agreement as poor if κ ≤ 0.20,
fair if 0.21 ≤ κ ≤ 0.40, moderate if 0.41 ≤ κ ≤0.60, substan-
tial if 0.61 ≤ κ ≤ 0.80 and good if κ > 0.80 [20]. All ana-
lyses were performed using STATA 12.1 and Microsoft
Excel. For subgroup analysis, the study population was
categorised by age group (<75 yrs and ≥75 yrs), sex,
CKD stage (stage 3 and stages 4/5), presence of comorbid-
ities (<3 and ≥3, excluding smoking status), with or with-
out a diagnosis of ischaemic heart disease or malignancy,
the Scottish Government 6-fold Urban Rural Classification
(1/2 (urban) and 3–6 (more rural) and SIMD quintiles (1–
3 (more deprived) and 4/5 (less deprived)). CKD stage was
assigned using the index eGFR.
This study was approved as part of GLOMMS-I, by the
University of Aberdeen Research Ethics Committee and the
NHS Grampian Caldicott Guardian and discussed with the
North of Scotland NHS Research Ethics Committee.
Results
Characteristics of study population
The baseline characteristics of the 3219 study participants
are summarised in Table 2. The cohort represents a rela-
tively elderly population, with a median age at index date
of 76.3 years. Forty-four per cent were male, 67.0% had
stage 3 CKD and 31.4% had at least three comorbidities.
Prevalence of comorbidities in GLOMMS-I
With the exception of cerebrovascular and chronic liver
diseases, the estimated prevalence of all comorbidities was
higher based on CNR compared with SMR01 (Figure 1
and Table 3), although differences were generally small.
Ischaemic heart disease had the highest prevalence in
SMR01 data at 35.6%, with similar CNR prevalence
(39.7%). Hypertension had the highest prevalence in CNR
data at 53.3%, however, hypertension was only recorded in
28.8% of the SMR01 data. Smoking status also showed a
difference with 48.6% recorded from CNR as current or
ex-smokers but only 0.7% in SMR01.
Table 2 Characteristics of the study population
Characteristic n %
Total 3219 l00.0
Sex
Male 1,414 43.9
Female 1,805 56.1
Age at index
Median age (years) 76.3
15-44 84 2.6
45-54 105 3.2
55-64 269 8.4
65-74 722 22.4
75-84 1,348 41.9
≥85 691 21.5
CKD stage at index
3 2.156 67.0
4 973 30.2
5 90 2.8
Number of morbidities*, †
0 315 9.8
1 896 27.8
2 1,002 31.1
3 643 20.0
4 272 85
5 73 2.3
6 16 0.5
7 2 0.1
Scottish government 6-fold urban rural classification*
1 Large urban areas 1,266 39.3
2 Other urban areas 513 15.9
3 Accessible small towns 266 8.3
4 Remote small towns 299 9.3
5 Accessible rural areas 498 15.5
6 Remote rural areas 338 10.5
Missing 39 1.2
SIMD 2009 quintlle*
1 most deprived 234 7.3
2 538 16.7
3 812 25.2
4 867 26.9
5 least deprived 729 22.7
Missing 39 1.2
SIMD, Scottish Index of Multiple Deprivation.
*based on case note review.
†excluding smoking status.
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comorbidities
Using CNR as the reference, kappa, sensitivity, specificity,
positive predictive value and negative predictive value for
each diagnosis are reported in Figure 1 and Table 3. For
most comorbidities, kappa values were ≥0.41, indicating at
least moderate agreement. Good agreement was found for
cerebrovascular disease with a kappa value of 0.80. Ischae-
mic heart disease and diabetes had substantial agreement,
with kappa values of 0.63 and 0.65 respectively. Hyperten-
sion, peripheral vascular disease and dementia showed only
fair agreement (κ = 0.28, 0.39, 0.38 respectively). Smoking
status showed poor agreement (κ = 0.01).
The sensitivity of SMR01 data generally reflected the
kappa value. Peripheral vascular disease showed a sensitiv-
ity of 87%, whereas smoking status sensitivity was only
1.1%. This means that most people with peripheral vascu-
lar disease recorded from CNR were also identified by
SMR01 whereas there were few smokers identified by
SMR01 data. However, the specificity of the SMR01 data
was generally very high, with all values over 85% and all
but three conditions having a specificity >95%. The nega-
tive predictive value was generally >80% except for hyper-
tension and smoking status. The positive predictive value
ranged between 49% and 94%, with both diabetes and
haematological malignancy being high, whereas chronic
liver disease and peripheral vascular disease were low.
Subgroup analysis
Results of the subgroup analysis are available in Additional
file 2. For some comorbidities, numbers were small, and
results should be interpreted with caution. Analysing
males and females separately, the prevalence of vascular
diseases (ischaemic heart disease, cerebrovascular disease,
peripheral vascular disease and congestive cardiac failure)
were all higher in males. The prevalence of dementia was
higher in females. Agreement was similar for the majority
of comorbidities, however for dementia the kappa value
was higher in females compared to males.
The prevalence of comorbidities showed higher vascular
diseases in those ≥75 years and higher rates of diabetes in
those <75 years. For ischaemic heart disease, congestive
cardiac failure, connective tissue disease, haematological
malignancy and chronic liver disease, kappa values were
higher for those <75 compared with those ≥75 years. The
majority of comorbidities showed no substantial differences
in kappa values comparing CKD stage 3 with CKD stages 4
and 5.
For most comorbidities, there was no substantial differ-
ence in agreement comparing those with <3 and ≥3 co-
morbidities. For peripheral vascular disease, congestive
cardiac failure, chronic obstructive pulmonary disease and
connective tissue disease, kappa values were higher in the
group with ≥3 compared with <3 comorbidities.
Figure 1 Prevalence, kappa agreement, sensitivity and specificity for SMR01 and case note review recorded comorbidity.
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prevalence of other vascular diseases. However, kappa
values were similar for those with and without ischae-
mic heart disease. We also compared patients with and
without a diagnosis of any malignancy in their case
notes. The prevalence of other comorbid disease was
lower in those with malignancy than those without, ex-
cept chronic obstructive pulmonary disease and currentTable 3 Agreement between SMR01 and case note review rec
Prevalence
Co-morbidity SMRO1 CNR Kappa*
n % n % Value Label
Ischaemic heart disease 1146 35.6 1277 39.7 0.63 Substantial 7
Hypertension 928 28.8 1715 53.3 0.28 Fair 4
Cerebrovascular disease 282 8.8 248 7.7 0.80 Substantial 8
Peripheral vascular 250 7.8 379 11.8 0.39 Fair 3
Congestive cardiac failure 511 15.9 546 17.0 0.45 Moderate 5
Diabetes mellitus 501 15.6 805 25.0 0.65 Substantial 5
Dementia 91 2.8 187 5.8 0.38 Fair 2
Chronic obstructive
pulmonary disease
255 7.9 283 8.8 0.51 Moderate 5
Connective tissue disease 140 4.3 154 4.8 0.54 Moderate 5
Haematological
malignancy
39 1.2 78 2.4 0.57 Moderate 4
Non-haematological
malignancy
300 9.3 454 14.1 0.51 Moderate 4
Chronic liver disease 37 1.1 33 1.0 0.51 Moderate 5
Current or ex-smoker 21 0.7 1564 48.6 0.01 Poor
SMRO1. Scottish Morbidity Record 01; PPV, Positive Predictive Value; NPV, Negative
*Interpretation of kappa: Agreement poor if κ ≤ 0.20, fair if 0.21κ ≤O.40, moderate ior ex-smoking status. For most of the comorbidities,
kappa values were similar.
Subgroup analysis for urban–rural classification showed
a slight trend for increased prevalence of all comorbidities
in those who lived in more urban areas. Comparing those
most and least deprived, there appeared to be a higher
prevalence of chronic obstructive pulmonary disease in
those in more deprived areas. However, kappa values wereorded comorbidity
Sensitivity Specificity PPV NPV
% 95% CI % 95% CI % 95% CI % 95% CI
2.8 (70.3-75.2) 88.9 (87.4-90.2) 81.2 (78.8-83.3) 83.3 (81.6-84.8)
2.4 (40.1-44.8) 86.7 (84.9-88.3) 78.4 (75.7-81.0) 56.9 (54.9-58.9)
7.1 (82.4-90.7) 97.8 (97.2-98.3) 76.6 (71.3-81.2) 98.9 (98.5-99.2)
6.9 (32.2-41.9) 96.1 (95.4-96.8) 56.0 (49.8-62.0) 92.0 (90.9-92.9)
2.4 (48.2-56.5) 91.6 (90.5- 92.6) 56.0 (51.6-60.2) 90.4 (89.2-91.5)
8.4 (54.9-61.7) 98.7 (98.2-99.1) 93.8 (91.4-95.6) 87.7 (86.4-88.9)
9.9 (23.8-36.9) 98.8 (98.4-99.2) 61.5 (51.3-70.9) 95.8 (95.1-96.5)
2.7 (46.8-58.4) 96.4 (95.7-97.0) 58.4 (52.3-64.3) 95.5 (94.7-96.2)
3.9 (46.0-61.6) 98.1 (97.6-98.6) 59.3 (51.0. 67.1) 97.7 (97.1-98.2)
3.6 (33.1 . 54.6) 99.8 (99.6-99.9) 87.2 (73.3-94.4) 98.6 (98.1-99.0)
7.1 (42.6-51.7) 96.9 (96.2-97.5) 71.3 (66.0-76.2) 91.8 (90.7-92.7)
4.5 (38.0-70.2) 99.4 (99.1-99.6) 48.6 (33.4-64.1) 99.5 (99.2-99.7)
1.1 (0.7-1.7) 99.8 (99.4-99.9) 81.0 (60.0-92.3) 51.6 (49.9-53.4)
Predictive Value; CI, Confidence Interval.
f 0.41κ ≤ 0.60, substantial if 0.61 ≤ 0.80 and good if κ > 0.80.
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Discussion
In this large population study, we compared clinician-
based case note review to routine hospital episode admin-
istrative data as methods of determining co-morbid status.
We compared the recording of 13 major health conditions
in a five year “look-back” period using administrative data
and a clinician-based assessment of the paper medical rec-
ord. Hospital data generally compared moderately well
with CNR. The prevalence of most conditions was lower
using the hospital administration data, and for most co-
morbidities, agreement was at least moderate. Similar
findings have been reported by others [8-10].
To the best of our knowledge, this is the largest valid-
ation study of comorbidity in a population based cohort,
and only the second comorbidity validation study in
people with CKD. The only other CKD study only vali-
dated 184 records [21]. The study cohort mostly com-
prised of elderly patients with a chronic disease. Our
findings may not relate to younger and healthier popula-
tions but, as a population based cohort, they are likely to
reflect well the findings for people with chronic disease.
Agreement was only fair for hypertension, peripheral vas-
cular disease and dementia and it was poor for smoking
status. For hypertension, the specificity was high, but only
42% of patients observed as hypertensive on CNR had
hypertension noted in their administrative data. This is not
unexpected. While hypertension is an important risk factor
for other conditions, it is generally managed in the out-
patient setting, and, with modern therapies, is uncommonly
a major reason for hospital admission. However, this is not
a consistent finding across all studies [9,10,21].
Smoking, the single most important risk factor for many
common chronic diseases, was barely recorded in the hos-
pital administration data, despite a high level of recording
in the case notes, and a high prevalence of current smokers.
This again reflects that smoking is rarely the main reason
for admission and is therefore, not recorded by hospital ad-
ministration data on discharge. The very low recording in
hospital administration data of factors such as hypertension
and smoking limits the utility of such data for research of
these important health risks. It also has major implications
for the utility of the data for health surveillance and service
planning. Yet, CNR demonstrates that the information was
recorded in clinical records and, with relatively minor
changes to recording procedures, this information could be
captured for future use or obtained from linkage to primary
care records where such information regarding risk factors
may be more complete.
To our knowledge, no other published studies have ex-
plored agreement between CNR and hospital episode data
methods of recording comorbidity in clinically importantsubgroups. The patterns of prevalence across subgroups
were as expected. For most comorbidities agreement be-
tween CNR and administrative data was similar across
subgroups. Agreement was less, however, in older ages
compared with data for those aged less than 75 years for
some important comorbidities. In patients with three or
more comorbidities, there was some evidence that admin-
istrative data performed better than for those without the
additional comorbid burden. This may reflect regular con-
tact with the health service resulting in more opportun-
ities to code other diagnoses in the administrative data, or
that for patients with complex healthcare needs and
resulting large paper based case records, case note review
becomes more challenging.
In this study, CNR data extraction was carried out by two
physicians experienced in nephrology and general medi-
cine. The physicians extracted information from different
case notes and there was no test of inter-rater reliability.
However, the data extraction was carried out prior to link-
age with SMR01 data, thus minimising measurement bias.
In addition, data entry was checked by an independent as-
sessor. The cohort was identified from electronic laboratory
records rather than recruited from a clinical setting and did
not, therefore, have issues of participation bias. Our pa-
tients were predominantly of northern European Caucasian
ethnicity and our findings may not be representative of
other ethnic groups. There were a number of methodo-
logical challenges, largely relating to the nature of the study,
which was not specifically designed for the purpose of val-
idation of comorbidity recording methods. There was a dif-
ference in the time periods for the extraction of the
administrative data and CNR data. The SMR01 data were
extracted for the period five years prior to the index date
whereas CNR recorded comorbidities at any time prior to
the index date. A diagnosis may be identified in CNR but
not in SMR01 data if there were no admissions in the five
years prior to the index date. However, the length of look
back period has been studied elsewhere [10,22,23]. Overall,
longer look-back periods were better at identifying those
with chronic disease.
This study demonstrates that routinely collected hos-
pital administrative data can reasonably be used to deter-
mine a profile of a patient’s comorbidity from across their
health records for the majority of conditions. Scottish hos-
pital episode data recording of individual hospital events,
recorded as part of service administration on hospital dis-
charge, is of high quality and similar completeness as that
of the rest of the UK [24]. The type of administrative data
assessed in this study could be generalizable to similar sys-
tems where diagnoses are captured as part of administra-
tive processes rather than “at the bedside” as part of the
clinical record. The Scottish administrative data system
was less able to detect risk factors such as smoking status
and hypertension, which are less likely to be coded from
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electronic patient record, it will be important that there
are continued efforts to code hospital events systematically
to provide vital summary information relating to both the
primary cause of admission and the associated significant
comorbidity information. The widespread approach of
making full text communication/records available, while a
vital component of the electronic patient record, is not
sufficient alone. The increasing use of coded recording in
outpatient settings and the ability to link to primary care
records will substantially improve the completeness of co-
morbidity recording, capturing conditions such as hyper-
tension and risk factors such as smoking that are generally
monitored in primary care. In the UK, payment by results
approaches such as the Quality and Outcomes Framework
have improved the regular recording of key risk factor in-
formation [25].
Conclusion
The use of administrative healthcare data is increasingly
important for understanding health and health care in re-
search, health surveillance and healthcare planning, as
recognised by the UK Department of Health [26]. This
study demonstrates that hospital administrative comorbid-
ity data generally compared moderately well with case note
review data for cerebrovascular disease, ischaemic heart
disease and diabetes, however there was significant under-
recording of some other comorbid conditions and risk fac-
tors. Knowledge of the strengths and limitations of data are
crucial for researchers and planners when interpreting
findings based on administrative healthcare data.
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